Bioray Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 25, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	695	635	930	901	1,290	826
Market Cap Growth	4.98%	-31.64%	3.17%	-30.18%	56.23%	-
Enterprise Value	592	586	911	896	1,226	756
Last Close Price	23.50	21.30	30.90	29.76	46.51	29.94
PE Ratio	22.92	634.18	-	1802.11	-	-
PS Ratio	3.02	3.15	4.85	4.73	8.72	5.29
PB Ratio	1.58	1.51	2.14	2.00	3.55	2.22
P/TBV Ratio	1.58	1.51	2.15	2.01	3.58	2.26
P/FCF Ratio	22.24	47.32	-	-	-	-
P/OCF Ratio	20.73	38.16	-	363.62	146.17	493.43
EV/Sales Ratio	2.57	2.90	4.75	4.70	8.29	4.84
EV/EBITDA Ratio	10.05	48.59	-	56.76	230.50	80.79
EV/FCF Ratio	18.93	43.61	-	-	-	-
Debt / Equity Ratio	0.12	0.20	0.16	0.22	0.15	0.17
Debt / EBITDA Ratio	0.87	4.26	13.55	4.68	4.99	4.11
Debt / FCF Ratio	1.64	6.39	-	-	-	-
Net Debt / Equity Ratio	-0.23	-0.22	-0.06	-0.08	-0.20	-0.23
Net Debt / EBITDA Ratio	-2.07	-7.67	16.42	-2.42	-13.70	-9.01
Net Debt / FCF Ratio	-3.31	-6.88	2.53	0.67	11.85	1.71
Asset Turnover	0.43	0.37	0.34	0.36	0.31	0.32
Inventory Turnover	2.17	2.40	2.10	2.24	1.72	2.10
Quick Ratio	5.30	5.33	3.52	2.77	2.20	2.33
Current Ratio	7.15	6.98	5.00	3.69	2.83	3.02
Return on Equity (ROE)	7.12%	0.23%	-2.61%	0.12%	-2.16%	-0.38%
Return on Assets (ROA)	4.13%	-0.50%	-2.12%	-0.04%	-1.08%	-0.03%
Return on Invested Capital (ROIC)	8.42%	-0.85%	-4.71%	-0.07%	-2.80%	-0.08%
Return on Capital Employed (ROCE)	7.40%	-0.90%	-3.90%	-0.10%	-2.10%	-0.10%
Earnings Yield	4.39%	0.16%	-1.24%	0.06%	-0.56%	-0.01%
FCF Yield	4.50%	2.11%	-1.16%	-6.34%	-0.48%	-5.97%
Dividend Yield	-	-	-	0.67%	-	-
Buyback Yield / Dilution	1.61%	0.83%	-7.37%	-4.67%	-0.14%	0.09%
Total Shareholder Return	1.61%	0.83%	-7.37%	-3.99%	-0.14%	0.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.